FDA acceptance of the new drug application for lonafarnib marks a key milestone toward an oral treatment option for chronic hepatitis D.
The recalled product is labeled Tyenne (tocilizumab-aazg) Injection 400mg/20mL (20mg/mL)20mL vials; Lot# 16UI07; NDC# 65219-594-20; Expiration Date of 08/2028. One lot of Tyenne ® (tocilizumab-aazg) ...
The 4C meningococcal B (MenB) vaccine confers modest protection against gonorrhea among adolescents, according to a study published online August 4 in Open Foru ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results